Remission of recurrent cervical cancer with paclitaxel and carboplatin: A case report and review of literature

European Journal of Gynaecological Oncology

Volumn 17, Issue 6, 1996, Pages 493-496

  Termrungruanglert, W ^a   Kudelka, A P ^b,d   Piamsomboon, S ^c   Edwards, C L ^b   Verschraegen, C F ^b   Loyer, E ^b   Kavanagh, J J ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TEXAS   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Box 39 ^*  (United States)

Author keywords

Carboplatin; Pacletaxel; Squamous cell carcinoma of the cervix

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE; REMISSION; SQUAMOUS CELL CARCINOMA; SUPRACLAVICULAR LYMPH NODE; UTERINE CERVIX CANCER;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; UTERINE CERVICAL NEOPLASMS;

EID: 0029827414     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wingo P. A., Tone T., Belden S.: "Cancer statistics", 1995. C. A. Cancer J. Clin. 1995, 45, 8.
2. Omura G. A.: "Chemotherapy for cervical cancer". Semin. Oncol., 1994, 21, 54.
3. Lopez A., Kudelka A. P., Edwards C. L., Kavanagh J. J.: "Carcinoma of the uterine cervix". In: Pazdur R., ed.: "Medical Oncology". Huntington, N.Y., P.R.R., 1996, 24, 393.
4. Kudelka A. P., Edwards C. L., Freedman R. S., Girtanner R., Kaplan A., Fishman A. et al.: "A phase I study of the toxicity, pharmacokinetic and activity of TNP-470 administered to patients with advanced or recurrent squamous cell cancer of the cervix". Proc. Am. Soc. Clin. Oncol., 1995, abstract 794.
5. Levy T., Kudelka A. P., Verschraegen C. F., Edwards C. L., Freedman R. S., Kaplan A. et al.: "A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix". Proc. Am. Assoc. Cancer Res., 1996. abstract 1140.
6. Kavanagh J. J., Kudelka A. P., Edwards C. L., Girtanner R. E., Durivage H. F., Howell E. T.: "CPT-11 (Irinotecan): phase II study in refractory squamous cell carcinoma of the cervix". Proc. Am. Assoc. of Cancer Res., 1994. abstract 1397.
7. Thigpen T., Vance R. B., Khansur T.: "Carcinoma of the uterine cervix: current status and future directions". Semin. Oncol., 1994, 21 (suppl. 2), 43.
8. Bonomi P., Blessing J. A., Stehman F., DiSaia P. J., Walton L., Major F. J.: "Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecoloaic Oncology Group study". J. Clin. Oncol., 1985, 3, 1079.
9. Coleman R. E., Harper P. G., Gallagher C., Osborne R., Rankin E. M., Silverstone A. C. et al.: "A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix". Cancer Chemother. Pharmacol. 1986, 18, 280.
10. Thigpen T.: "Chemotherapy of advanced or recurrent cervical cancer", In: Rubin S., Hoskins W. J. (eds.). "Cervical and preinvasive neoplasm". New York, NY, Raven, 1995 (in press).
11. Takeuchi S. Noda K., Yakushiji M.: "Late phase II study of CPT-11. topoisomerase-1 inhibitor, in advanced cervical carcinoma". Proc. Am. Soc. Clin. Oncol., 1992. abstract 224.
12. McGuireW. P. III, Arseneau J., Blessing J. A., DiSaia P. J., Hatch K. D., Given F. T et al.: "A randomized comparative trial of carboplatm and iproplatin in advanced squamous carcinoma of the uterine cervix. A Gynecologic Oncology Group study". J. Clin. Oncol., 1989, 7, 1462.
13. Lira-Puerto V., Silva A., Morris M., Martinez R., Groshen S., Morales-Canfield F. et al.: "Phase II trial of carboplatin or iproplatin in cervical cancer". Cancer Chemother. Pharmacol., 1991, 28, 391.
14. [14) Weiss G. R., Green S., Hannigan E. V., Boutselis J. G., Surwit E. A., Wallace D. L. et al.: "A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study". Gynecol. Oncol., 1990, 39, 332.
15. Muggia F. M., Muderspach L.: "Platinum compounds in cervical and endometrial cancers: focus on carboplatin". Semin. Oncol., 1994, 2 (suppl. 2). 35.
16. Buxton E. J., Meanwell C. A., Hilton C., Mould J. J., Spooner D., Chetiyawardana A. et al.: "Combination bleomycin, ifosfamide and cisplatin chemotherapy in cervical cancer". J. Natl. Cancer Inst., 1989, 81, 359.
17. Murad A. M., Triginelli S. A., Ribalta J. C. L.: "Phase II trial of bleomycin, ifosfamide. and carboplatin in metastatic cervical cancer". J. Clin. Oncol., 1994, 12, 55.
18. Friedlander M., Kaye S. B., Sullivan A., Atkinson K., Elliott P., Coppleson M., et al.: "Cervical carcinoma: a drug-responsive tumor-experience with combined cisplatin, vinblastine, and bleomycin therapy". Gynecol. Oncol., 1983, 16, 275.
19. Chan W. K., Aroney R. S., Levi J. A., Tattersal M. H. N., Fox R. M., Woods R. L.: "Four-drug combination chemotherapy for advanced cervical carcinoma". Cancer, 1982, 49, 2437.
20. Ramm K., Vergote I. B., Kaerm J., Trope C. G.: "Bleomycin-ifosfamide-cisplatin (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look". Gynecol. Oncol., 1992, 46, 203.
21. Thigpen T., Vance R. B., Khansur T.: "The platinum compounds and paclitaxel in the management of carcinoma of the endometrium and uterine cervix". Semin. Oncol., 1995, 22 (suppl. 12), 67.